Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$16.2M
total disclosed, rounds participated
Stages
—
About
Founded by Gil Aharon Ph.D. and Steven Salamon P.Eng. CFA in Toronto, Canada, Rosalind Advisors, Inc. manages life-sciences focused funds.
Our biotech funds’ strategy is market agnostic, operating at the intersection of science and finance with the goal of capitalizing on consistent market inefficiencies and arbitrage opportunities. Since its founding in 2006, the fund has had a consistent track-record of uncorrelated abnormal returns.
Portfolio · 1
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Rosalind Advisors' primary investment focus?
- Rosalind Advisors manages life-sciences focused funds, operating at the intersection of science and finance.
- Where is Rosalind Advisors headquartered?
- Rosalind Advisors is headquartered in Toronto, Canada.
- When was Rosalind Advisors founded?
- Rosalind Advisors was founded in 2006 by Gil Aharon Ph.D. and Steven Salamon P.Eng. CFA.
- What is a notable company in Rosalind Advisors' portfolio?
- Rosalind Advisors has invested in PolyPid, a company focused on Polymer Lipid Encapsulation Technology.
- In which sector does Rosalind Advisors primarily invest?
- Rosalind Advisors shows a concentration in the Health Tech & Life Sciences sector, with all recorded portfolio companies and investment rounds falling within this area.
- What type of funding stage has Rosalind Advisors participated in recently?
- In January 2024, Rosalind Advisors participated in a PIPE funding stage.
- What is the investment range for Rosalind Advisors?
- Rosalind Advisors' investment range is between $16.2M and $16.2M.
- When did Rosalind Advisors make its most recent recorded investment?
- Rosalind Advisors made its most recent recorded investment in January 2024.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | rosalindcap.com/ |
|---|